WASHINGTON (Reuters) -U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, ...

Trump specifically asked that those companies offer the MFN price to Medicaid recipients and to promise that they wouldn't ...

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a ...

President Donald Trump sent letters to 17 of the world’s largest pharmaceutical companies — including Eli Lilly & Co., Novo ...

President Donald Trump sent letters to 17 leading pharmaceutical manufacturers, including Eli Lilly (NYSE:LLY), Pfizer ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

President Donald Trump has sent letters to the CEOs of 17 pharmaceutical companies demanding action to address high prescription drug costs in the United States, the White House announced Thursday.